TY - CHAP M1 - Book, Section TI - Cystic Fibrosis A1 - Hunt, William R. A1 - Tong, David A1 - Stecenko, Arlene A2 - McKean, Sylvia C. A2 - Ross, John J. A2 - Dressler, Daniel D. A2 - Scheurer, Danielle B. PY - 2017 T2 - Principles and Practice of Hospital Medicine, 2e AB - Key Clinical Questions How do mutations in the cystic fibrosis (CF) gene relate to the clinical manifestations of the disease? What criteria help determine when a CF patient should be admitted to the hospital for respiratory complications of the disease? What treatment modalities are most effective in restoring lung function to baseline for CF respiratory exacerbations? Why is CF-related diabetes (CFRD) important to control during acute pulmonary exacerbations as well as at baseline? What are the most effective treatment modalities for the two most common pulmonary complications of CF: massive hemoptysis and pneumothorax? SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accessmedicine.mhmedical.com/content.aspx?aid=1137623287 ER -